Evaluation Of A Novel Methodology In The Assessment Of Urethral Function Using SS-RBX.

Pfizer

Status and phase: Completed; Phase 2

Conditions: Urinary Incontinence, Stress

Treatments: Drug: SS-RBX

Study type: Interventional

Funder types: Industry

Identifiers

NCT00141128

A6061024

Details and patient eligibility

About

SS-RBX will be used to evaluate pharmacodynamic changes in urethral function using a novel methodology

Enrollment: 18 patients

Sex: Female

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Female
• Stress urinary incontinence

Exclusion criteria

• Bladder outflow obstruction
• Neurological disease

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: Double Blind